Value-based pricing in economic crisis
- At: 2010 FIP Congress in Lisbon (Portugal)
- Type: Poster
- By: BJöRNSDóTTIR, Ingunn (Research Institute for Pharmaceutical Outcomes and Policy, University of Iceland, ReykjavÍk, Iceland)
- Co-author(s): Hauksdóttir, Rúna (Icelandic Medicine Pricing and Reimbursement Committee, REYKJAVIK, Iceland)
Background: Since 2007 Iceland has increased cooperation with Sweden in registration and reimbursement decisions. Due to the economic crisis, cutting costs was urgently needed in 2009, when changes were initiated, aiming at fewer reimbursed pharmaceuticals and tailoring use towards the less costly. Changes are effective for 6 drug classes and.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.